Abiraterone plus prednisone improves survival in metastatic castration-resistant prostate cancer.

TitleAbiraterone plus prednisone improves survival in metastatic castration-resistant prostate cancer.
Publication TypeJournal Article
Year of Publication2011
AuthorsTagawa ST, Beltran H
JournalAsian J Androl
Volume13
Issue6
Pagination785-6
Date Published2011 Nov
ISSN1745-7262
KeywordsAndrostenes, Androstenols, Antineoplastic Combined Chemotherapy Protocols, Enzyme Inhibitors, Humans, Male, Neoplasm Metastasis, Orchiectomy, Prednisone, Prostatic Neoplasms
DOI10.1038/aja.2011.113
Alternate JournalAsian J. Androl.
PubMed ID21857690
PubMed Central IDPMC3739559